Waters Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Waters Corporation (WAT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $9.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-23
- Waters Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $9.00M, a 35.71% decline from fiscal 2024.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $14.00M, a 27.27% increase from fiscal 2023.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $11.00M, a 64.52% decline from fiscal 2022.
- Waters Corporation share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $31.00M, a 27.91% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2025-12-31 | $9.00M 10-K · filed 2026-02-23 |
| 2024-12-31 | $14.00M 10-K · filed 2026-02-23 |
| 2023-12-31 | $11.00M 10-K · filed 2026-02-23 |
| 2022-12-31 | $31.00M 10-K · filed 2025-02-25 |
| 2021-12-31 | $43.00M 10-K · filed 2024-02-27 |
| 2020-12-31 | $45.00M 10-K · filed 2023-02-27 |
| 2019-12-31 | $45.00M 10-K · filed 2022-02-24 |
| 2018-12-31 | $44.00M 10-K · filed 2021-02-24 |
| 2017-12-31 | $76.00M 10-K · filed 2020-02-25 |
| 2016-12-31 | $53.00M 10-K/A · filed 2019-03-01 |
| 2015-12-31 | $48.00M 10-K · filed 2018-02-27 |
| 2014-12-31 | $63.00M 10-K · filed 2017-02-24 |
| 2013-12-31 | $64.00M 10-K · filed 2016-02-26 |
| 2012-12-31 | $31.00M 10-K · filed 2015-02-27 |
| 2011-12-31 | $67.00M 10-K · filed 2014-02-27 |
| 2010-12-31 | $45.00M 10-K · filed 2013-02-26 |
| 2009-12-31 | $13.00M 10-K · filed 2012-02-24 |
| 2008-12-31 | $26.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |